Beam Therapeutics Inc. (BEAM) Discusses Topline Phase I/II Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency - Slideshow (NASDAQ:BEAM) 2026-03-27
Beam Therapeutics(US:BEAM) Seeking Alpha·2026-03-28 07:14技术访问问题 - 用户需在浏览器中启用Javascript和cookie以确保正常访问 [1] - 启用广告拦截器可能导致访问受阻 建议用户禁用广告拦截器并刷新页面 [1]